A CatalyCEST MRI Contrast Agent that Can Simultaneously Detect Two Enzyme Activities
Related Experiment Video
Updated: Mar 28, 2026

Simultaneous PET/MRI Imaging During Mouse Cerebral Hypoxia-ischemia
Published on: September 20, 2015
Gabriela Fernández-Cuervo1, Sanhita Sinharay2, Mark D Pagel3
1Department of Pharmaceutical Sciences, University of Arizona, 1515 N. Campbell Ave., Tucson, AZ, 85724, USA.
Abstract:
The simultaneous detection of multiple enzyme activities can improve the specificity of disease diagnoses. We therefore synthesized and characterized a diamagnetic chemical exchange saturation transfer (CEST) MRI contrast agent that can simultaneously detect two enzyme activities. Sulfatase and esterase enzymes cleave the ligands of the CEST agent, releasing salicylic acid that can be detected with CEST MRI. Importantly, both enzymes are required to activate the agent to produce a CEST MRI contrast, and the CEST agent was stable without enzyme treatment. These results established that this diamagnetic CEST MRI contrast agent is a platform technology with a modular design that can be potentially exploited to detect other combinations of enzyme activities, which can expand the armamentarium of contrast agents for molecular imaging.

